NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
1.32
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-0.08 Insider Own55.84% Shs Outstand671.61M Perf Week3.94%
Market Cap1.05B Forward P/E- EPS next Y-0.20 Insider Trans0.33% Shs Float350.18M Perf Month-2.94%
Enterprise Value1.10B PEG- EPS next Q-0.11 Inst Own32.10% Short Float8.85% Perf Quarter-22.35%
Income-39.03M P/S1.52 EPS this Y-326.79% Inst Trans27.65% Short Ratio8.64 Perf Half Y-12.58%
Sales689.37M P/B0.68 EPS next Y40.17% ROA-1.90% Short Interest31.00M Perf YTD-10.20%
Book/sh1.95 P/C2.40 EPS next 5Y-11.20% ROE-3.04% 52W High2.04 -35.14% Perf Year3.13%
Cash/sh0.55 P/FCF- EPS past 3/5Y-18.15% 32.04% ROIC-2.33% 52W Low1.19 10.92% Perf 3Y-49.81%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-26.21% -4.59% Gross Margin20.02% Volatility3.28% 3.55% Perf 5Y-49.81%
Dividend TTM- EV/Sales1.60 EPS Y/Y TTM82.82% Oper. Margin-39.05% ATR (14)0.05 Perf 10Y-91.43%
Dividend Ex-Date- Quick Ratio2.28 Sales Y/Y TTM-13.79% Profit Margin-5.66% RSI (14)48.68 Recom1.29
Dividend Gr. 3/5Y- - Current Ratio2.49 EPS Q/Q13.04% SMA20-0.77% Beta1.35 Target Price3.99
Payout- Debt/Eq0.37 Sales Q/Q-13.66% SMA50-1.17% Rel Volume0.53 Prev Close1.32
Employees2997 LT Debt/Eq0.28 EarningsApr 30 AMC SMA200-12.88% Avg Volume3.59M Price1.32
IPONov 02, 1995 Option/ShortYes / Yes EPS/Sales Surpr.-45.77% -8.74% Trades Volume1,888,843 Change0.00%
Date Action Analyst Rating Change Price Target Change
Apr-25-25Initiated JP Morgan Neutral
Jun-29-23Upgrade Barrington Research Mkt Perform → Outperform $2
Dec-15-22Initiated H.C. Wainwright Buy $3
Jan-24-22Downgrade Barrington Research Outperform → Mkt Perform
Jun-21-21Initiated Ladenburg Thalmann Buy $7
Nov-25-19Initiated Piper Jaffray Overweight $2.50
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Jun-25-25 11:00AM
08:00AM
Jun-24-25 03:52PM
Jun-13-25 12:37PM
Jun-09-25 08:00AM
08:00AM Loading…
May-15-25 08:00AM
May-01-25 12:43PM
08:57AM
03:17AM
Apr-30-25 07:52PM
06:30PM
05:50PM
04:47PM
04:05PM
Apr-22-25 09:35AM
09:38AM Loading…
Apr-17-25 09:38AM
08:00AM
Apr-11-25 04:05PM
Apr-04-25 08:00AM
Mar-28-25 09:35AM
Mar-18-25 11:37AM
Mar-17-25 08:00AM
Mar-14-25 06:59PM
12:07PM
Mar-12-25 12:10PM
11:06AM
Mar-11-25 07:00AM
Feb-28-25 09:01AM
02:35AM
Feb-27-25 10:45PM
07:00PM Loading…
07:00PM
06:50PM
05:58PM
04:10PM
Feb-25-25 09:15AM
Feb-13-25 04:05PM
Feb-12-25 09:15AM
Jan-27-25 08:00AM
Jan-20-25 10:02PM
Jan-09-25 11:45AM
Jan-07-25 08:00AM
Dec-11-24 02:08AM
Dec-10-24 08:00AM
Nov-29-24 02:43PM
Nov-20-24 08:00AM
Nov-18-24 08:00AM
Nov-15-24 08:34PM
Nov-14-24 06:00AM
Nov-08-24 04:05PM
04:01AM
Nov-07-24 10:15PM
08:00PM
06:40PM
05:35PM
04:05PM
08:00AM
Oct-29-24 04:05PM
Oct-07-24 08:00AM
08:00AM
Sep-25-24 08:30AM
Sep-23-24 08:00AM
Sep-16-24 07:30AM
Aug-09-24 04:05PM
Aug-08-24 12:14PM
12:15AM
Aug-07-24 08:00PM
06:59PM
04:06PM
Aug-01-24 04:05PM
Jul-18-24 08:00AM
Jul-17-24 04:14PM
Jul-08-24 06:54PM
12:30PM
Jul-02-24 08:00AM
Jun-06-24 11:31AM
May-31-24 10:48AM
10:00AM
May-12-24 03:24PM
May-09-24 09:18AM
May-08-24 11:47AM
06:56AM
03:44AM
May-07-24 09:15PM
08:30PM
06:09PM
05:30PM
04:38PM
04:05PM
May-03-24 08:00AM
Apr-01-24 01:01PM
Mar-28-24 11:08PM
08:00AM
Mar-25-24 09:57AM
Mar-20-24 08:00AM
Mar-05-24 08:52AM
Feb-29-24 08:31AM
Feb-28-24 09:31AM
09:02AM
06:18AM
Feb-27-24 09:00PM
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanApr 10 '25Buy1.36125,000169,712214,001,448Apr 10 05:07 PM
FROST PHILLIP MD ET ALCEO & ChairmanApr 08 '25Buy1.48125,000184,650213,876,448Apr 08 05:34 PM
FROST PHILLIP MD ET ALCEO & ChairmanApr 01 '25Buy1.65100,000164,850213,751,448Apr 01 05:21 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 28 '25Buy1.70150,000254,385213,651,448Mar 28 05:22 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 17 '25Buy1.74200,000347,820213,501,448Mar 17 05:27 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28 '25Buy1.7167,434115,312213,301,448Feb 28 07:34 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 28 '25Buy1.4747,53770,060213,234,014Jan 28 05:40 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 17 '25Buy1.47150,000220,425213,186,477Jan 17 05:06 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 15 '25Buy1.48500,000740,850213,036,477Jan 15 05:18 PM
FROST PHILLIP MD ET ALCEO & ChairmanDec 13 '24Buy1.59125,000199,375212,536,477Dec 13 05:04 PM
FROST PHILLIP MD ET ALCEO & ChairmanDec 11 '24Buy1.56500,000781,050212,411,477Dec 11 05:21 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 29 '24Buy1.53199,072305,376211,911,477Nov 29 03:20 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 22 '24Buy1.59100,000159,000211,712,405Nov 22 05:17 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 14 '24Buy1.62100,000161,980211,612,405Nov 14 05:51 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 08 '24Buy1.50280,183421,535211,512,405Nov 08 05:40 PM
OPKO HEALTH, INC.10% OwnerSep 17 '24Proposed Sale40.8813,404547,956Sep 20 02:56 PM
OPKO HEALTH, INC.10% OwnerAug 19 '24Sale34.4950,0001,724,5202,646,972Aug 19 05:23 PM
OPKO HEALTH, INC.10% OwnerAug 16 '24Sale34.3050,0001,714,8502,696,972Aug 19 05:23 PM
OPKO HEALTH, INC.10% OwnerAug 15 '24Sale33.0839,8241,317,5052,746,972Aug 19 05:23 PM
OPKO HEALTH, INC.10% OwnerAug 12 '24Sale33.9559,7872,029,8112,811,783Aug 14 04:50 PM
OPKO HEALTH, INC.10% OwnerAug 13 '24Sale34.7624,987868,5032,786,796Aug 14 04:50 PM
OPKO HEALTH, INC.10% OwnerAug 08 '24Sale31.82100,0003,182,3802,871,570Aug 08 05:39 PM
OPKO HEALTH, INC.10% OwnerAug 06 '24Sale29.3512,994381,4272,971,570Aug 08 05:39 PM
OPKO HEALTH, INC.10% OwnerJul 31 '24Sale33.5088,8392,976,3462,984,564Aug 02 04:21 PM
OPKO HEALTH, INC.10% OwnerJul 29 '24Sale33.8650,0001,692,8903,073,403Jul 31 05:03 PM
OPKO HEALTH, INC.10% OwnerJul 24 '24Sale33.7275,0002,529,1053,183,403Jul 26 07:49 PM
OPKO HEALTH, INC.10% OwnerJul 26 '24Sale33.8560,0002,031,2583,123,403Jul 26 07:49 PM
OPKO HEALTH, INC.10% OwnerJul 23 '24Sale33.4675,0002,509,2453,258,403Jul 23 05:16 PM
OPKO HEALTH, INC.10% OwnerJul 22 '24Sale32.6150,0001,630,4403,333,403Jul 23 05:16 PM
OPKO HEALTH, INC.10% OwnerJul 19 '24Sale32.2925,000807,2503,383,403Jul 23 05:16 PM
OPKO HEALTH, INC.10% OwnerJul 17 '24Sale32.9325,000823,1883,408,403Jul 19 06:46 PM
OPKO HEALTH, INC.10% OwnerJul 05 '24Sale28.2436,1181,020,0163,433,403Jul 09 04:07 PM
OPKO HEALTH, INC.10% OwnerJul 02 '24Sale29.1225,000728,0953,483,603Jul 03 04:56 PM
OPKO HEALTH, INC.10% OwnerJul 03 '24Sale28.2314,082397,4913,469,521Jul 03 04:56 PM